Copeptin for risk stratification in acute illness: beyond cardiological problems

Copeptin (Cop) has been recently proposed as a reliable marker for the diagnosis of acute coronary syndrome, altough its concentration was found to increase in a variety of other severe clinical conditions. The aim of the present study was to assess the utility of Cop to identify high-risk patients...

Full description

Bibliographic Details
Main Authors: Roberto Cemin, Giuseppe Lippi, Luca Donazzan, Massimiliano Manfrin, Massimo Daves
Format: Article
Language:English
Published: PAGEPress Publications 2013-10-01
Series:Emergency Care Journal
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/ecj/article/view/1183
_version_ 1828220877297156096
author Roberto Cemin
Giuseppe Lippi
Luca Donazzan
Massimiliano Manfrin
Massimo Daves
author_facet Roberto Cemin
Giuseppe Lippi
Luca Donazzan
Massimiliano Manfrin
Massimo Daves
author_sort Roberto Cemin
collection DOAJ
description Copeptin (Cop) has been recently proposed as a reliable marker for the diagnosis of acute coronary syndrome, altough its concentration was found to increase in a variety of other severe clinical conditions. The aim of the present study was to assess the utility of Cop to identify high-risk patients in the emergency room (ER). Eighty-five patients admitted to ER of the San Maurizio Regional Hospital of Bolzano between February to March 2010 with epigastric or chest pain and/or discomfort were included in the study. Blood was drawn at admission and sampled for Cop in standard laboratory tests. Cop levels were significantly higher in patients who died at the hospital or shortly afterwards as compared with survivors (median 61 vs 40.6 pmol/L; P=0.014). Cop levels were also higher in patients with severe health problems (62.9 vs 28.3 pmol/L; P<0.0001). The area under the receiver-operating characteristic curve of Cop was 0.70 for in-hospital death [95% confidence interval (CI) 0.53-0.86], 0.74 for acute and subacute death (95% CI 0.61-0.87) and 0.90 for prediction of severe acute illness (95% CI 0.84-0.97). Accordingly, a Cop level >33.1 pmol/L correctly identified in-hospital death with 71% sensitivity and 74% specificity. A Cop level >13.6 pmol/L was instead associated with 89% sensitivity and 80% specificity for identifying patients with acute and severe conditions. The results of our analysis would suggest that the use of Cop may be a valuable aid in the ER for identifying patients with life-threatening conditions.
first_indexed 2024-04-12T16:32:56Z
format Article
id doaj.art-7b5071837d3f47939722f69dafa12ec2
institution Directory Open Access Journal
issn 1826-9826
language English
last_indexed 2024-04-12T16:32:56Z
publishDate 2013-10-01
publisher PAGEPress Publications
record_format Article
series Emergency Care Journal
spelling doaj.art-7b5071837d3f47939722f69dafa12ec22022-12-22T03:25:04ZengPAGEPress PublicationsEmergency Care Journal1826-98262013-10-0192e19e1910.4081/ecj.2013.e191275Copeptin for risk stratification in acute illness: beyond cardiological problemsRoberto Cemin0Giuseppe Lippi1Luca Donazzan2Massimiliano Manfrin3Massimo Daves4Department of Cardiology, San Maurizio Regional Hospital of Bolzano, BolzanoLaboratory of Clinical Chemistry and Hematology, Parma University Hospital, ParmaDepartment of Cardiology, San Maurizio Regional Hospital of Bolzano, BolzanoDepartment of Cardiology, San Maurizio Regional Hospital of Bolzano, BolzanoClinical Biochemistry Laboratory, San Maurizio Regional Hospital of Bolzano, BolzanoCopeptin (Cop) has been recently proposed as a reliable marker for the diagnosis of acute coronary syndrome, altough its concentration was found to increase in a variety of other severe clinical conditions. The aim of the present study was to assess the utility of Cop to identify high-risk patients in the emergency room (ER). Eighty-five patients admitted to ER of the San Maurizio Regional Hospital of Bolzano between February to March 2010 with epigastric or chest pain and/or discomfort were included in the study. Blood was drawn at admission and sampled for Cop in standard laboratory tests. Cop levels were significantly higher in patients who died at the hospital or shortly afterwards as compared with survivors (median 61 vs 40.6 pmol/L; P=0.014). Cop levels were also higher in patients with severe health problems (62.9 vs 28.3 pmol/L; P<0.0001). The area under the receiver-operating characteristic curve of Cop was 0.70 for in-hospital death [95% confidence interval (CI) 0.53-0.86], 0.74 for acute and subacute death (95% CI 0.61-0.87) and 0.90 for prediction of severe acute illness (95% CI 0.84-0.97). Accordingly, a Cop level >33.1 pmol/L correctly identified in-hospital death with 71% sensitivity and 74% specificity. A Cop level >13.6 pmol/L was instead associated with 89% sensitivity and 80% specificity for identifying patients with acute and severe conditions. The results of our analysis would suggest that the use of Cop may be a valuable aid in the ER for identifying patients with life-threatening conditions.http://www.pagepressjournals.org/index.php/ecj/article/view/1183copeptin, risk stratification, emergency room
spellingShingle Roberto Cemin
Giuseppe Lippi
Luca Donazzan
Massimiliano Manfrin
Massimo Daves
Copeptin for risk stratification in acute illness: beyond cardiological problems
Emergency Care Journal
copeptin, risk stratification, emergency room
title Copeptin for risk stratification in acute illness: beyond cardiological problems
title_full Copeptin for risk stratification in acute illness: beyond cardiological problems
title_fullStr Copeptin for risk stratification in acute illness: beyond cardiological problems
title_full_unstemmed Copeptin for risk stratification in acute illness: beyond cardiological problems
title_short Copeptin for risk stratification in acute illness: beyond cardiological problems
title_sort copeptin for risk stratification in acute illness beyond cardiological problems
topic copeptin, risk stratification, emergency room
url http://www.pagepressjournals.org/index.php/ecj/article/view/1183
work_keys_str_mv AT robertocemin copeptinforriskstratificationinacuteillnessbeyondcardiologicalproblems
AT giuseppelippi copeptinforriskstratificationinacuteillnessbeyondcardiologicalproblems
AT lucadonazzan copeptinforriskstratificationinacuteillnessbeyondcardiologicalproblems
AT massimilianomanfrin copeptinforriskstratificationinacuteillnessbeyondcardiologicalproblems
AT massimodaves copeptinforriskstratificationinacuteillnessbeyondcardiologicalproblems